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Abstract 
Background: Acute myocardial infarction (AMI) remains as one of the most common lethal 
diseases in the world and therefore it is necessary to understand its effect on molecular basis. 
Genome-wide microarray analysis provides us to predict potential biomarkers and signaling 
pathways for this purpose.  
Objectives: The aim of this study is to understand the molecular basis of the immediate right 
ventricular cellular response to left ventricular AMI. 
Material and Methods: A rat model of left anterior descending coronary artery ligation was 
used to assess the effect of left ventricular AMI on both the right ventricle as a remote zone 
and the left ventricle as an ischemic/infarct zone. Microarray technology was applied to detect 
the gene expression. Gene Ontology and KEGG pathways analysis were done to identify 
effected pathways and related genes. 
Results: We found that immune response, cell chemotaxis, inflammation, cytoskeleton or-
ganization are significantly deregulated in ischemic zone as early response within 30 min. 
Unexpectedly, there were several affected signaling pathways such as cell chemotaxis, regu-
lation of endothelial cell proliferation, and regulation of caveolea regulation of anti-apoptosis, 
regulation of cytoskeleton organization and cell adhesion on the remote zone in the right 
ventricle. 
Conclusion: This data demonstrates that there is an immediate molecular response in both 
ventricles after an AMI. Although the ischemia did not histologically involve the right ventricle; 
there is a clear molecular response to the infarct in the left ventricle. This provides us new 
insights to understand molecular mechanisms behind AMI and to find more effective drug 
targets. 
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INTRODUCTION 
Gene  expression  microarray  technology, 
founded in the 1990s, which is designed to detect mil-
lions of gene targets simultaneously, has been devel-
oped for the purpose of analyzing the effects of vari-
ous agents on tissue gene expression level. It has also 
been used to detect the gene expression in myocardial 
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cells at infarction or remote zone samples [1, 2]. My-
ocardial infarction is a leading cause of cardiovascular 
morbidity  and  mortality.  After  infarction,  a  repair 
process is initiated that strongly depends on vascular 
status. Rapid angiogenesis and residual vascular po-
tency are important to the re-establishment of coro-
nary collateral circulation and to the improvement of 
blood supply to the infarction zone and its periphery. 
Although many studies have focused on the role of 
growth factors in revascularization after myocardial 
ischemia,  specifically  on  the  expression  of  growth 
factors and their application in therapeutic angiogen-
esis and on arterial blood supply through coronary 
revascularization, there is no knowledge about how 
other  ventricles  which  is  anatomically  far  from  is-
chemic area integrate to this response [3-6]. This study 
was  undertaken  to  delineate  molecular  processes 
underlying the response of right ventricular cells to 
MI after ligation of the left anterior descending coro-
nary  artery  in  rats.  Successful  MI  compensation  in-
volved  early  remote  zone  gene  activation  those  are 
including an acute phase response, initiation of a cy-
toprotective  program,  recruitment  of  extensive  de-
velopmental  transcription  factors  and  induction  of 
signaling pathways associated with cell proliferation. 
Despite  overriding  transcriptional  depression,  the 
infarct  zone  exhibited  an  early  cytoprotective  re-
sponse through recruitment of different gene families 
than the remote zone [7-9]. 
MATERIAL AND METHOD 
Animals and experimental model  
Adult  Wistar  albino  rats,  weighing  250–300  g, 
were  obtained  from  the  Laboratory  Animal  Science 
Department,  Dokuz  Eylül  University,  and  İzmir, 
Turkey.  All  experimental  animal  procedures  were 
approved by Local Ethical Committee of Dokuz Eylül 
University  Animal  Care  and  Use.  Animals  were 
housed  in  controlled  environmental  conditions  and 
had  free  access  to  a  standard  diet  and  tap  water. 
Animals were maintained in controlled rooms with 12 
hours light/dark cycle and a pathogen free facility. 
The  rats  were  divided  in  2  groups;  Sham-operated 
rats  (SHAM  group),  coronary  artery  ligation  group 
(MI group). Sham-operated rats underwent identical 
surgical procedure except suture of coronary artery. 
The  acute  myocardial  infraction  (AMI)  model  was 
carried out by left coronary artery ligation according 
to  the  reports  (Hochman  and  Bulkley,  1982).  Rats 
were anesthetized with intra peritoneal ketamine (35 
mg/kg) and xylazine (15  mg/kg) fixed  in a  supine 
position being shaved on the chest and then intubated 
with opening tracheotomy. Positive pressure respira-
tion (10-15 ml/kg tidal volume, 60 breath/min) was 
started with FiO2 100% (Hugo sacs rodent ventilator, 
Germany). Under sterile conditions, right carotid ar-
tery exteriorizes and a catheter filled with heparinized 
saline was inserted into the artery, the catheter was 
connected through a pressure transducer to the mon-
itor,  arterial  pressure  monitored.  Then,  left  inter-
costals’  thoracotomy  was  performed  and  the  third 
and  fourth  intercostals’  ribs  were  separated  with  a 
small retractor to expose the heart. The pericardium 
was opened. Anterior transmural AMI was created by 
occlusion  of  the  left  anterior  descending  coronary 
artery with a 6-0-10 mm a traumatic proline silk su-
ture  which  passed  through  the  epicardial  layer 
around  the  midway  of  the  left  anterior  descending 
coronary artery. Following coronary occlusion, arte-
rial  blood  gases,  heart  rate,  rectal  temperature  and 
arrhythmias  were  recorded.  After  scarification  and 
hearts were dissected at the end of thirtieth minute, 
tissue samples were taken out from ischemic from left 
ventricles and non-ischemic zones from right ventri-
cles in both SHAM and MI groups, separately. 
Histological examination  
Remaining heart tissue was immersed in a buff-
ered 10 % formalin solution and then embedded in 
paraffin for histopathological study. Parallel samples 
were then separately fixed in 10 % formal-saline, de-
hydrated  through  graded  alcohol  series,  cleared  in 
xylene and embedded in paraffin wax Serial sections 
of 5 µm thickness were cut, stained with Hematoxylin 
and eosin (HE) and used for the assessment of histo-
pathological changes. Some sections were subjected to 
Masson’s Trichrome (MT) for collagen staining. The 
sections were examined under light and electron mi-
croscope. Histological analysis of the infarct zone re-
vealed that tissue integrity was abnormal including 
regional  vacuolation  and  disruption  of  myofibrils 
organization  with  interstitial  hemorrhagic  foci, 
broadly  disorganized  interstitial  tissue  and  global 
disruption of sarcomeric organization including con-
traction band necrosis. 
RNA extraction and amplification 
Following  all  operations,  tissues  were  washed 
with ice cold PBS and store at -80 in RNAlatter. These 
tissues  were  snapping  frozen  in  liquid  nitrogen, 
pounded with mortal and pestle then homogenized 
with 20g syringe and qia-shredder. Total RNA from 
homogenized  myocardial  tissues  was  extracted  by 
using fibrous tissue RNA isolation kit as the manu-
facturer’s recommended protocol (Qiagen CA, USA). 
The quantity and purity of RNA were determined by 
measuring A260 and A280. Integrity of RNA was de-Int. J. Med. Sci. 2012, 9 
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termined  with  1.5%  formaldehyde  agarose  gel  elec-
trophoresis. RNA bands were visualized with staining 
samples with ethidium bromide.  
Gene expression microarray 
10 ug of RNA was used to synthesize first and 
then second strand cDNA by using One-Cycle cDNA 
Synthesis Kit. Poly-A control RNA was amplified for 
intensity normalization during microarray scanning. 
After cleanup of second strand cDNA target labeling 
was  performed.  Biotinylated  cRNA  samples  were 
prepared  according  to  the  standard  Affymetrix 
GeneChip®  protocol.  Quantity  of  cRNA  was  meas-
ured  by  using  UV  spectrophotometry.  After  cRNA 
was fragmented, Affymetrix GeneChip® Expression 
3'  Amplification  One-Cycle  Target  Labeling  kit  was 
used.  The  biotin  labeled  cRNA  molecules  were  hy-
bridized with GeneChip® Rat Genome 230 2.0 arrays 
(Affyimetrix),  consisting  of  31.000  probe  sets  which 
analyze the expression level of over 30.000 transcripts 
and variants from over 28.000 rat genes. Probes were 
scanned using a GeneChip® Scanner 7G and analysis 
of the array image was configured using GeneChip® 
operating software. 
Microarray Data Analysis 
Normalization of the raw gene expression data 
was performed using RMA (Robust Multi-Array Av-
erage) normalization method in Babelomics gene ex-
pression and functional profiling analysis suite (ver-
sion 4.2) [10]. The normalized intensity values of rep-
licated  probes  in  each  array  were  averaged  before 
performing  data  analysis.  Differentially  expressed 
genes  were  screened  among  the  four  groups;  (i) 
SHAM/ischemic  (ii)  SHAM/remote  zone  (iii) 
MI/ischemic  (iv)  MI/remote  zone  by  using  fold 
change analysis of Babelomics tool. The fold change 
threshold was >= 2.0 in defining up or down regu-
lated  genes  between  the  groups.  Functional  charac-
terization  of  the  set  of  genes  obtained  from  group 
comparisons  was  identified  using  WebGestalt 
(Web-based Gene Set Analysis Toolkit V2) online tool 
[11]. The following annotation types were selected for 
the functional analysis; Gene Ontology (GO) Biologi-
cal Processes, Molecular Functions, Cellular Compo-
nents and KEGG (Kyoto Encyclopaedia of Genes and 
Genomes) Pathways. 
RESULTS 
Histological Analysis 
Histological  analysis  of  infarcts  revealed  hem-
orrhagic foci, broadly disorganized interstitial tissue 
and global disruption of sarcomeric organization in-
cluding  contraction  band  necrosis  (Figure  1  A,  B). 
Infarct  histopathology  included  significant  vacuolar 
regions,  reduced  cardiomyocyte  populations,  sarco-
meric  and  cellular  disorganization  and  invasive  fi-
brotic  tissue.  The  region  dissected  as  remote  zone 
(right ventricle), exhibited gross  histological charac-
teristics  those  obtained  from  the  remote  zone  of 
shams. 
The  effect  of  the  experimental  protocol  apart 
from  the  ligation  procedure  was  determined  by 
comparison of expression in sham animals over the 
study duration. Thus, the effect of experimental MI 
was  superimposed  on  a  dynamic  back  ground  in 
which  sham  animals  rapidly  recovered  from  the 
thoracotomy. 
 
Fig.1, Histopathology of the infarct zone obtained after LADC ligation. The upper panels are representative sections of 
infarct obtained from an animal 30
th min after LADC ligation stained with hematoxylin and eosin (A) or trichrome (B). The 
gross external appearance of this region was unremarkable except for regional discoloration. Histological analysis revealed 
that tissue integrity was abnormal including regional vacuolation and disruption of myofibrils organization with interstitial 
hemorrhagic foci and intermittent cellular infiltrates. Int. J. Med. Sci. 2012, 9 
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Differentially regulated genes in ischemic 
zones from left ventricles 
It was identified that there were 49 differentially 
regulated  transcripts  with  2.0  or  more  fold  change 
after the comparison of the SHAM/ischemic zone and 
MI/ischemic zone taken from both on left ventricles. 
While 31 out of 49 transcripts were up-regulated in 
the  MI/ischemic  zone,  18  transcripts  were  altered 
their  expression  level  in  the  direction  of 
down-regulation (Supplementary File 1). Total 49 of 
genes significantly changed in MI/ischemic zone, the 
up-regulated gene, FBJ osteosarcoma oncogene (Fos), 
had the highest fold-change, and its fold-change value 
was  4.5.  However,  the  gene  family  with  sequence 
similarity  107,  member  A  (Fam107a)  with  2.8 
fold-changes  was  the  most  down-regulated  gene  in 
the  gene  list  obtained  by  performing  fold-change 
screening. To generate both functionally and biologi-
cally relevant group of genes, WebGestalt toolkit was 
used.  Differentially  regulated  genes  were  grouped 
into  3  different  GO  domains  (Biological  Processes, 
Molecular Functions and Cellular Components) and 
their  relevant  KEGG  pathways  were  identified.  GO 
enrichment  analysis  of  total  49  transcripts  showed 
that the large number of genes was in “binding” (41 
genes)  (GO:  0005488,  p=0.0007),  “intracellular”  (35 
genes) (GO: 0005622, p=0.0377), “response to chemical 
stimulus”  (17  genes)  (GO:  0042221,  p=3.78e-05)  and 
“response to stress” (13 genes) (GO: 0006950, p=0.0041) 
ontological categories. Additionally, it was observed a 
significance  in  the  following  GO  terms  after  per-
forming enrichment analysis of significant gene list; 
“taxis”  (5  genes)  (GO:0042330,  p=5.26e-05),  “inflam-
matory response” (6 genes) (GO:0006954, p=0.0008) and 
“transcription activator activity” (2 genes) (GO:0016563, 
p=0.0444) (Table  1).  Furthermore,  it  was  found  sig-
nificantly changed 6 KEGG pathways in response to 
coronary artery-ligation in MI/ischemic zone (Table 
2) (p<0.05). 
 
Table 1. GO enrichment analysis MI ischemic and remote zones in response to LCAL. 
Gene Ontology term  SHAM/ischemic vs. MI/ischemic zone  SHAM/remote vs. MI/remote zone 
  p-value  # of Genes  p-value  # of Genes 
- Response to chemical stimulus (GO:0042221)  3.78e-05  17  0.0021  27 
-Response to corticosteroid stimulus (GO:0031960)  0.0030  4  0.0041  6 
- Chemotaxis (GO:0006935)  5.26e-05  5  0.0038  5 
- Cell chemotaxis (GO:0060326)  4.53e-05  4  0.0016  4 
- Leukocyte chemotaxis (GO:0030595)  3.37e-05  4  0.0012  4 
- Neutrophil chemotaxis (GO:0030593)  1.00e-04  3  N/A  not significant 
- Leukocyte migration (GO:0050900)  0.0002  4  N/A  not significant 
- Immune response (GO:0006955)  0.0004  8  N/A  not significant 
- Inflammatory response (GO:0006954)  0.0008  6  N/A  not significant 
- Chemokine activity (GO:0008009)  1.71e-07  5  N/A  not significant 
- Cytokine activity (GO:0005125)  5.55e-05  5  N/A  not significant 
- Catecholamine metabolic process (GO:0006584)  0.0128  2  N/A  not significant 
- Binding (GO:0005488)  0.0007  41  0.0085  104 
- Protein binding (GO:0005515)  0.0123  32  0.0120  80 
-Cytokine receptor binding (GO:0005126)  1.00e-04  5  N/A  not significant 
-Chemokine receptor binding (GO:0042379)  2.02e-07  5  0.0005  4 
- Calcium ion binding (GO:0005509)  0.0463  5  0.0083  12 
- Heparin binding (GO:0008201)  0.0277  2  N/A  not significant 
- Intracellular (GO:0005622)  0.0377  35  0.0006  94 
- Actin cytoskeleton (GO:0015629)  0.0055  4  N/A  not significant 
- Myosin complex (GO:0016459)  0.0004  3  N/A  not significant 
- Response to vitamin (GO:0033273)  not significant  N/A  0.0012  6 
- Response to calcium ion (GO:0051592)  not significant  N/A  0.0052  4 
- Response to amino acid stimulus (GO:0043200)  not significant  N/A  0.0006  4 Int. J. Med. Sci. 2012, 9 
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Gene Ontology term  SHAM/ischemic vs. MI/ischemic zone  SHAM/remote vs. MI/remote zone 
  p-value  # of Genes  p-value  # of Genes 
- Regulation of anti-apoptosis (GO:0045767)  not significant  N/A  0.0010  4 
- Caveola assembly (GO:0070836)  not significant  N/A  1.00e-04  2 
- Regulation of cytoskeleton organization (GO:0051493)  not significant  N/A  0.0002  7 
-Regulation of microtubule cytoskeleton organization 
(GO:0070507) 
not significant  N/A  0.0011  4 
-Actin polymerization or depolymerization (GO:0008154)  not significant  N/A  0.0033  4 
- Regulation of endothelial cell proliferation (GO:0001936)  not significant  N/A  0.0036  3 
- Lipid binding (GO:0008289)  not significant  N/A  0.0090  9 
-Diacylglycerol binding (GO:0019992)  not significant  N/A  0.0079  3 
-Fatty acid binding (GO:0005504)  not significant  N/A  0.0007  4 
- Mitochondrion (GO:0005739)  not significant  N/A  0.0113  22 
- Cytoplasmic vesicle (GO:0031410)  not significant  N/A  0.0195  12 
-Perinuclear region of cytoplasm (GO:0048471)  not significant  N/A  0.0425  6 
- Cytosol (GO:0005829)  not significant  N/A  0.0006  24 
-Ribonucleoprotein complex (GO:0030529)  not significant  N/A  0.0079  9 
- Envelope (GO:0031975)  not significant  N/A  0.0197  11 
-Cytoplasmic membrane-bounded vesicle (GO:0016023)  not significant  N/A  0.0219  11 
- Mitochondrial envelope (GO:0005740)  not significant  N/A  0.0389  8 
 
 
 
Differentially regulated genes in remote zone 
on right ventricles 
It was found that 143 genes were differentially 
regulated  between  the  SHAM/remote  zone  and 
MI/remote  zone  groups  taken  from  both  on  right 
ventricles (Supplementary File 2). While 32 out of 143 
genes were significantly down-regulated, other genes 
were increased in their expression level 2.0 or more as 
fold  change.  Among  the  differentially  expressed 
genes, Caveolin-1 (Cav1) was the most increased gene 
with  4.6  fold  change.  Additionally,  Family  with  se-
quence  similarity  111,  member  A  (Fam111a)  and 
3-Phosphoinositide  dependent  protein  kinase-1 
(Pdpk1)  genes  were  the  most  two  down-regulated 
genes with 2.9 fold change. 
GO functional enrichment analysis of  the both 
up and down-regulated genes in remote zones was 
revealed  the  significance  of  distinct  GO  terms  as 
shown in Table 1. We found that differentially regu-
lated genes mainly were collected in certain GO terms 
including  “response  to  chemical  stimulus”  (27  genes) 
(GO:0042221, p=0.0021), “response to stress” (25 genes) 
(GO:0006950, p=0.0059), “response to abiotic stimulus” 
(15  genes)  (GO:0009628,  p=2.35e-05),  “binding”  (104 
genes) (GO:0005488, p=0.0085) and “intracellular part” 
(94 genes) (GO:0044424, p=0.0006) “Caveola assembly” 
(2 genes) (GO:0070836 p= 1.00e-04), “Regulation of an-
ti-apoptosis” (2 genes) (GO:0045767 p=0.0010), “Regu-
lation  of  cytoskeleton  organization”  (7  genes) 
(GO:0051493  p= 0.0002)  “Regulation of endothelial cell 
proliferation” (3 genes) (GO:0001936 p= 0.0036). Fur-
thermore, GO term enrichment analysis of the gene 
set  including  143  differentially  regulated  genes 
showed significance in the following GO terms; “reg-
ulation  of  endothelial  cell  proliferation”  (3  genes) 
(GO:0001936,  p=0.0036),  “taxis”  (5  genes) 
(GO:0042330,  p=0.0038)  “sarcoplasm”  (3  genes) 
(GO:0016528,  p=0.0075)  and  “vesicle”  (12  genes) 
(GO:0031982,  p=0.0309).  The  most  remarkable  gene 
alterations found in only remote zone were grouped 
as “regulation of endothelial cell proliferation”, “Caveola 
assembly”  “Regulation of anti-apoptosis”,  and  “Regula-
tion of cytoskeleton organization” Go terms showed in 
figure 2 A, B, C, D respectively. Behind to the analysis 
of  GO  term  distribution  of  the  significant  genes, 
KEGG  pathway  analysis  identified  11  pathways 
which  were  significantly  altered  by  comparing  the 
remote zones of the groups (Table 2) (p<0.05). 
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Table 2. KEGG pathways in response to LCAL in MI ischemic and remote zones. 
KEGG Pathway name  Corresponding genes  p-value 
SHAM/ischemic zone and MI/ischemic zone comparison 
NOD-like receptor signaling pathway  Cxcl2, Cxcl1, Ccl2, Ccl7  1.65e-05 
Chemokine signaling pathway  Cxcl2, Cxcl1, Ccl2, Ccl7, Cxcl10  0.0002 
Focal adhesion  Col1a1, Pdpk1, Mylpf, Arhgap5  0.0033 
Leukocyte transendothelial migration  Mylpf, Arhgap5, Cybb  0.0063 
Cytokine-cytokine receptor interaction  Cxcl2, Ccl2, Cxcl10  0.0172 
Toll-like receptor signaling pathway  Fos, Cxcl10  0.0260 
SHAM/remote zone and MI/remote zone comparison 
Adherens junction  Actb, Ctnnb1, Csnk2a1  0.0315 
Tight junction  Prkci, Actb, Ctnnb1, Myl7, Ppp2r1a, Csnk2a1  0.0014 
Focal adhesion  Col1a1, Actb, Pdpk1, Cav1, Ctnnb1, Myl7, Cav2  0.0022 
Regulation of actin cytoskeleton  Arpc2, Cfl1, Pfn1, Actb, Myl7  0.0432 
Viral myocarditis  Actb, Cav1, Eif4g2, RT1-Ba  0.0027 
Arrhythmogenic right ventricular cardiomyopathy 
(ARVC) 
Cacna2d1, Dsc2, Actb, Ctnnb1  0.0039 
NOD-like receptor signaling pathway  Cxcl1, Hsp90ab1, Ccl2  0.0103 
PPAR signaling pathway  Fabp4, Pdpk1, Dbi  0.0315 
Ubiquitin mediated proteolysis  Ube2g1, Ube2s, Map3k1, Nedd4  0.0309 
Spliceosome  Nhp2l1, Snrpf, Lsm7, Smndc1  0.0258 
Ribosome  Rps10, Rps24, Rpl34  0.0354 
 
 
Fig. 2, SHAM/remote zone and MI/remote zone comparison of altered genes in Gene Ontology terms. Int. J. Med. Sci. 2012, 9 
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Common differentially regulated genes in is-
chemic zones from left ventricles and remote 
zone from right ventricles 
There were only 9 altered transcripts which were 
identified as common genes in remote and ischemic 
zones. It was found that the genes  chemokine (C-C 
motif) ligand 2 (Ccl2), chemokine (C-X-C motif) ligand 
10  (Cxcl10)  and  chemokine  (C-X-C  motif)  ligand  1 
(melanoma growth stimulating activity, alpha) (Cxcl1) 
were up-regulated in both remote and ischemic zones 
of the rats. CD93 molecule (Cd93), Pdpk1 and calcium 
channel,  voltage-dependent,  alpha2/delta  subunit  1 
(Cacna2d1)  were  up-regulated  in  ischemic  zone; 
however, those were identified as down-regulated in 
remote zone. Additionally, the genes collagen, type I, 
alpha 1 (Col1a1), DDB1 and CUL4 associated factor 6 
(Dcaf6)  and  prefoldin  subunit  6  (Pfdn6)  were 
down-regulated  in  ischemic  zones  of  the  coronary 
artery-ligated rats while those were up-regulated in 
the remote zone. 
DISCUSSION 
Acute myocardial infarction is the interruption 
of blood supply to a part of the heart, causing heart 
cells to die. This is most commonly due to occlusion of 
a coronary artery following the rupture of a vulnera-
ble atherosclerotic plaque, which is an unstable col-
lection of lipids and white blood cells mostly macro-
phages in the wall of an artery. The resulting ischemia 
and oxygen shortage, if left untreated for a sufficient 
period of time, can cause damage or death of heart 
muscle tissue. Despite modern reperfusion therapies, 
acute myocardial infarction remains associated with 
the development of heart failure in a significant pro-
portion  of  patients  [12,  13].  Many  therapeutic  ap-
proaches  designed  to  limit  injury  after  infarct  are 
based on empirical observation of efficacious clinical 
outcomes associated with myocardial reperfusion or 
reduced  cardiac  work.  These  include:  1.  Pharmaco-
logical  manipulation  e.g.  angioten-
sin-converting-enzyme (ACE) inhibitors, β-adrenergic 
blockers (β-blockers) and statins, 2. Coronary artery 
bypasses graft surgery and 3. Interventional cardiol-
ogy methods for example stents and angioplasty. Re-
cently,  it  has  been  suggested  that  maladaptive 
changes  in  cardiac  contractility  are  associated  with 
activation  of  a  fetal  gene  program  by  pathologic 
stimuli [14- 18]. While the data supporting this idea 
are limited, validation of this hypothesis could pro-
vide  novel  targets  for  therapeutic  intervention  after 
MI either at the level of transcription or via the in-
ductive signal transduction pathways triggering these 
pathways  [16].  In  this  study  we  hypothesized  that 
there may be global transcriptional alterations in right 
ventricle which is accepted as remote zone as an early 
response  against  ischemia  following  myocardial  in-
farction at left ventricle. These molecular alterations 
give us new insights for the novel therapeutic targets 
against  AMI  or  to  understand  how  collaterals  im-
proved  without  any  lethal  damage  in  the  heart  tis-
sues. 
MI response attributes to regional effects of is-
chemia  on  several  physiological  systems  across  di-
verse  cardiac  components  including  the  contractile 
apparatus,  the  extracellular  matrix  (ECM)  and  the 
vasculature [16, 19]. In many studies, increased levels 
of different markers of inflammation have been asso-
ciated with AMI as an early response within 24 h. In 
our study it has been shown that immune response 
was one of the most remarkable results as an imme-
diate response (30min) in after ligation of the left an-
terior descending coronary artery (LADCA) in rats. At 
this  point  we  should  emphasize  that  the  measured 
molecular responses to AMI in the infarct and remote 
location  were  performed  at  30  minutes  only. 
Measurements either earlier of later would be helpful 
in future experiments to assess the progression and 
change in molecular responses to AMI. 
This immune response has been validated with 
other  significantly  changed  conditions  such  as  in-
flammatory  response,  chemokine  activity,  cytokine 
activity, cytokine receptor binding, neutrophil chem-
otaxis, and leukocyte chemotaxis and leukocyte mi-
gration.  Furthermore,  expression  of  chemokine  lig-
ands (Cxcl1, Ccl2, Cxcl2, Ccl7, and Cxcl10) increased in 
the infarct zone. It is known that these ligands recruit 
leucocytes (such as monocytes), memory T cells, and 
dendritic cells to sites of tissue injury, infection, and 
inflammation [20]. Hence, it is expected to an increase 
in chemotaxis of immune cells towards infarct zone as 
following  increase  level  of  ligands.  Moreover,  Ca++ 
ion  binding  related  genes  also  deregulated  in  tran-
scriptional level in the ischemic zone in MI rat. While 
level  of  Cacna2d1  increased,  Myosin  light  chain  3, 
skeletal muscle isoform (Myl1), Myosin Light Chain, 
Phosphorylatable,  Fast  Skeletal  Muscle  (Mylpf)  and 
Troponin C type 2 (Tnnc2) transcripts decreased un-
der the effect of ischemia. This  molecular signature 
shows us the ischemia possibly causes loss of muscle 
construction due to alterations in Ca current density 
as a sudden effect. The alterations in the expression of 
Myl1 and Mylpf genes emphasized that change in Ca 
level effects on cytoskeleton organization of myocytes 
in ischemic area. Indeed, regulation of actin cytoskel-
eton,  myosin  complex  and  contractile  fiber  related 
genes were significantly changed in ischemic zone. Int. J. Med. Sci. 2012, 9 
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Although  dynamic  changes  in  distinct  remote 
and ischemic zones were studied in AMI rat model, 
there was no data available for the alterations in the 
area  out  of  left  ventricle  in  which  MI  produced  by 
ligation. As the first time in literature we use of right 
ventricle as remote zone in the present study. Histo-
logical analysis proved no ischemia in the right ven-
tricle. Interestingly, there were several significant al-
terations in the level of transcript of genes which can 
be grouped in immune response, cytoskeleton organ-
ization, angiogenesis, and mitochondrial metabolism. 
Although  immune  response,  cytoskeleton  organiza-
tion  and  calcium  metabolism  related  genes  were 
changed in a similar manner in both remote and is-
chemic  zones,  anti-apoptosis,  lipid  metabolism,  en-
dothelial  cell  proliferation  and  Caveolae-  related 
genes were deregulated only in remote zone as early 
response  to  AMI.  Lipid  rafts  represent  a  subcom-
partment  of  the  plasma  membrane  that  coordinate 
and  regulate  varieties  of  signaling  processes  while 
caveolins  are  the  integral  membrane  protein  of  the 
lipid raft. It is demonstrated that lipid raft play a piv-
otal role in the generation of survival signal in pre-
conditioning or adapted heart and disintegration of 
lipid  raft  completely  abolish  cardioprotection  [19]. 
Caveolae, lipid-rich microdomains of the sarcolemma, 
localize and enrich cardiac-protective signaling. Cav1 
is the main coat protein of caveolae and is expressed 
by different vascular cells [22-24]. Caveolae and Cav1 
have emerged as novel targets in the control of vari-
ous  important  cellular  processes  involved  in  the 
maintenance  of  cardiovascular  homeostasis  such  as 
protein  trafficking,  lipid  metabolism  and  signal 
transduction [25]. Cardiac-specific overexpression of 
Caveolin  3  (Cav3)  induces  endogenous  cardiac  pro-
tection by mimicking ischemic/preconditioning [20]. 
In  the  present  study,  Cav1  and  Caveolin  2  (Cav2) 
genes were significantly up regulated in remote zone. 
Thus,  we  suggested  that  remote  zone  might  sense 
ischemia  with  an  unknown  mechanism  and  altered 
lipid raft configuration to provide signals for cardio-
protection and/or endothelial cell proliferation. The 
other  very  interesting  result  was  alterations  on  the 
mitochondrion,  mitochondrial  envelope  and  regula-
tion  of  anti-apoptosis  gene  in  remote  zone.  Mito-
chondria  are  the  main  organelle  in  cell  for  energy 
metabolism and the control of intrinsic way of apop-
tosis. So, it is acceptable to increase ATP hydrolysis 
and anti-apoptotic genes in remote zone as we found 
in our analysis. Because cells in remote zones possibly 
intended to survive and proliferate toward ischemic 
zone as a very early response. Moreover, analysis our 
data  in  KEGG  pathways  showed  us  tight  junction, 
adherent  junction,  focal  adhesion  genes  were  also 
deregulated. These deregulations were highly similar 
with  viral  myocarditis  and  arrhythmogenic  right 
ventricular  cardiomyopathy  [26-29].  Cytoskeleton, 
mitochondrial and lymphocytic changes marked viral 
myocarditis  and  desmosome,  cytoskeleton,  inflam-
mation, calcium transport and apoptosis changes in-
dicates the appearance of similar phenotypic altera-
tions  with  arrhythmogenic  right  ventricular  cardio-
myopathy and dilated cardiomyopathy in the remote 
zone [19, 20]. 
As  a  conclusion  molecular  findings  supposed 
that signals through the infarct zone is able to force 
remote zone to survive by the way of endothelial pro-
liferation,  angiogenesis,  mitochondrial  changes, 
apoptotic  regulation.  Validation  of  this  hypothesis 
could provide novel targets for therapeutic interven-
tion after MI. 
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